The existence of a small molecule inhibitor (MCC950), which targets the NLRP3 inflammasome [33], suggests more effective ways to both prevent and treat the inflammatory symptoms of tuberculosis-associated IRIS and should be explored in future studies. This evidence concerns the gene NLRP3 and tuberculosis.